-
1 Comment
Apyx Medical Corporation is currently in a long term uptrend where the price is trading 8.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.0.
Apyx Medical Corporation's total revenue rose by 35.5% to $11M since the same quarter in the previous year.
Its net income has increased by 100.0% to $-2K since the same quarter in the previous year.
Finally, its free cash flow grew by 61.0% to $-1M since the same quarter in the previous year.
Based on the above factors, Apyx Medical Corporation gets an overall score of 5/5.
| Exchange | NASDAQ |
|---|---|
| Sector | Healthcare |
| Industry | Medical Devices |
| CurrencyCode | USD |
| ISIN | US03837C1062 |
| Market Cap | 36M |
|---|---|
| PE Ratio | None |
| Target Price | 4 |
| Beta | 0.92 |
| Dividend Yield | None |
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for APYX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
